Boston (dbTechno) - The U.S. Food and Drug Administration has approved a new drug, Cimzia, to help treat people suffering from Crohn’s disease.

The new drug is manufactured in the U.S. and is called Cimzia.

The FDA has approved the drug for adults with moderate to severe Crohn’s disease who have not responded to other treatment methods.

Crohn’s disease affects more than 1 million men and women worldwide.

It is a chronic inflammatory bowel disease and can cause diarrhea, rectal bleeding, abdominal pain, fever, etc.

Cimzia works by reducing the symptoms of Crohn’s disease.

It affects the immune system, but because of this can alter the body’s ability to fight infections, making people vulnerable.

It is being kept as a drug to use on patients suffering, only when conventional treatments do not work.